Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lisa Beth Nachtigall, M.D.

Concepts (251)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Lisa Nachtigall's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Lisa Nachtigall has written about over time.
Pituitary Apoplexy, 2 publications between 2004 and 2021, average publication date September 2012. Ergolines, 3 publications between 2009 and 2017, average publication date July 2013. Peptides, Cyclic, 3 publications between 2010 and 2016, average publication date July 2014. Hyperprolactinemia, 6 publications between 2009 and 2022, average publication date January 2015. Insulin-Like Growth Factor I, 14 publications between 2006 and 2022, average publication date May 2015. Adenoma, 12 publications between 2004 and 2024, average publication date August 2015. Hypopituitarism, 6 publications between 2008 and 2019, average publication date August 2015. Human Growth Hormone, 11 publications between 2008 and 2024, average publication date January 2016. Pituitary Neoplasms, 14 publications between 2004 and 2024, average publication date June 2016. Somatostatin, 7 publications between 2010 and 2021, average publication date April 2017. Pituitary ACTH Hypersecretion, 4 publications between 2012 and 2024, average publication date August 2017. Acromegaly, 23 publications between 2006 and 2024, average publication date October 2017. Gadolinium, 2 publications between 2019 and 2019, average publication date February 2019. Adrenal Insufficiency, 3 publications between 2012 and 2024, average publication date June 2019. Hyperparathyroidism, Primary, 1 publications between 2020 and 2020, average publication date May 2020. Multiple Endocrine Neoplasia Type 1, 1 publications between 2020 and 2020, average publication date May 2020. Growth Hormone-Secreting Pituitary Adenoma, 4 publications between 2016 and 2024, average publication date June 2020. Octreotide, 5 publications between 2020 and 2024, average publication date September 2022. Antineoplastic Agents, Hormonal, 2 publications between 2024 and 2024, average publication date April 2024.

To see the data from this visualization as text, click here.
Nachtigall's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (251)
Explore
_
Co-Authors (65)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.